Search research articles
Contact Us
Filters
Showing results (41-50 of 123) with videos related to
Page
of 13
Sort By:
Pediatric Blood & Cancer
|
January 7, 2020
Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis
Irene Jiménez, Marick Laé, Marie-Laure Tanguy, et al.
Molecular Genetics & Genomic Medicine
|
October 1, 2019
Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome?
Marion Imbert-Bouteille, Marion Gauthier-Villars, Dominique Leroux, et al.
Cancer
|
March 15, 2012
Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection
Gabriel G Malouf, Laurence Brugières, Marie-Cécile Le Deley, et al.
Plos Genetics
|
March 2, 2016
A Parent-of-Origin Effect Impacts the Phenotype in Low Penetrance Retinoblastoma Families Segregating the c.1981C>T/p.Arg661Trp Mutation of RB1
Philippine Eloy, Catherine Dehainault, Meriem Sefta, et al.
Environmental Research
|
October 21, 2023
Residential proximity to vines and risk of childhood embryonal tumours in France - GEOCAP case-control study, 2006-2013
Danielle Awounou, Matthieu Mancini, Brigitte Lacour, et al.
Oncotarget
|
October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors
Andrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma
Heribert Juergens, Najat C Daw, Birgit Geoerger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 18, 2016
Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours
Didier Frappaz, Sara M Federico, Andrew D J Pearson, et al.
Targeted Oncology
|
March 16, 2026
Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial
Alba Rubio-San-Simón, Lynley V Marshall, Eleni Karamouza, et al.
Journal of the National Cancer Institute
|
November 6, 2010
MDM2 as a modifier gene in retinoblastoma
Laurent Castéra, Audrey Sabbagh, Catherine Dehainault, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 123) with videos related to
Sort By:
Page
of 13
Pediatric Blood & Cancer
|
January 7, 2020
Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis
Irene Jiménez, Marick Laé, Marie-Laure Tanguy, et al.
Molecular Genetics & Genomic Medicine
|
October 1, 2019
Osteosarcoma without prior retinoblastoma related to RB1 low-penetrance germline pathogenic variants: A novel type of RB1-related hereditary predisposition syndrome?
Marion Imbert-Bouteille, Marion Gauthier-Villars, Dominique Leroux, et al.
Cancer
|
March 15, 2012
Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection
Gabriel G Malouf, Laurence Brugières, Marie-Cécile Le Deley, et al.
Plos Genetics
|
March 2, 2016
A Parent-of-Origin Effect Impacts the Phenotype in Low Penetrance Retinoblastoma Families Segregating the c.1981C>T/p.Arg661Trp Mutation of RB1
Philippine Eloy, Catherine Dehainault, Meriem Sefta, et al.
Environmental Research
|
October 21, 2023
Residential proximity to vines and risk of childhood embryonal tumours in France - GEOCAP case-control study, 2006-2013
Danielle Awounou, Matthieu Mancini, Brigitte Lacour, et al.
Oncotarget
|
October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors
Andrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 26, 2011
Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma
Heribert Juergens, Najat C Daw, Birgit Geoerger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 18, 2016
Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumours
Didier Frappaz, Sara M Federico, Andrew D J Pearson, et al.
Targeted Oncology
|
March 16, 2026
Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Combination with Chemotherapy in Children with Advanced Malignancies: Arm K of the AcSé-ESMART Trial
Alba Rubio-San-Simón, Lynley V Marshall, Eleni Karamouza, et al.
Journal of the National Cancer Institute
|
November 6, 2010
MDM2 as a modifier gene in retinoblastoma
Laurent Castéra, Audrey Sabbagh, Catherine Dehainault, et al.
Page
of 13